|
|
Annual general meeting has been held in SciBase Holding AB (publ) |
|
|
SciBase strengthens the US organization with experienced leader in dermatology |
|
|
Interim report |
|
|
Today is the first day of trading in the new shares and warrants of series TO 2 issued in connection with the completed capital raising |
|
|
SciBase receives first order in Austria |
|
|
SciBase Announces the launch of eBarrier Score, the First AI-Driven Skin Barrier Assessment tool for research and Cosmetic Testing |
|
|
New German study shows Nevisense significantly improves dermatologists clinical decisions |
|
|
SciBase publishes the Annual report for 2023 |
|
|
SciBase announces outcome in the directed issue of units |
|
|
Notice to attend the annual general meeting in SciBase Holding AB (publ) |
